Pharmaceutical Executive
All News
Advertisement
Advertisement
Pharmaceutical Executive
Click the title above to open the Pharmaceutical Executive May 2018 issue in an interactive PDF format.
Pharmaceutical Executive
Pharmaceutical Executive
Insights from Partnering with IDNs: Biopharma Strategy Summit.
Advertisement
Pharmaceutical Executive
Pharmaceutical Executive
Pharmaceutical Executive
This article discusses the supply chain benefits of pharma companies distributing from South Florida.
Advertisement
Pharmaceutical Executive
This op-ed discusses the varying skills that business leaders should look at in scientists when thinking about talent for the lab and the executive suite.
Pharmaceutical Executive
Leela Barham reviews the Institute for Clinical Effectiveness Review's announced pilot program, which allow manufacturers to scrutinize executable versions of draft cost-effectiveness models.
Pharmaceutical Executive
Click the title above to open the Pharmaceutical Executive April 2018 issue in an interactive PDF format.
In terms of important clinical benefits and outcomes, modern biotech products have rarely shown the advantages of older generations of drugs, writes Bagrat Lalayan.
Pharmaceutical Executive
Pharmaceutical Executive
Pharmaceutical Executive
Pharmaceutical Executive
Pharmaceutical Executive
Pharmaceutical Executive
Click the title above to open the Pharmaceutical Executive March 2018 issue in an interactive PDF format.
Advertisement
Advertisement
Trending on PharmExec
1
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
2
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
3
Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising, Alleging Misleading Dosing Comparisons
4
Developing Better Drugs, Not Just More Drugs: Q&A with David Hung
5